New Program Delivers CompuMed`s CardioGram and CardioGramKids To Schools
LOS ANGELES–(Business Wire)–
CompuMed, Inc. (OTCBB:CMPD) (http://www.compumed.net), a telemedicine and
medical informatics company, has partnered with the nonprofit California School
Health Centers Association (CSHC) to promote CompuMed`s CardioGram® and
CardioGramKids®electrocardiogram (ECG) telemedicine technologies for use in
school health centers throughout California. CSHC represents more than 150
school health centers that serve more than 800 primary and secondary schools
throughout California.

The new partnership calls for CompuMed to provide ECG equipment and interpretive
over-reads for screenings, while CSHC will promote CompuMed`s ECG telemedicine
technologies via its website, e-Newsletters, and statewide and regional
conferences, as well as through other initiatives to be developed. CompuMed has
already recently participated in CSHC regional conferences in Los Angeles and
Oakland.

“Public-private partnerships, like this introduction of CompuMed`s ECG
telemedicine technology into school-based health centers, provide students and
parents with access to important diagnostic services that might otherwise be
unavailable or impractical, especially during periods of public budgetary
uncertainty,” said CSHC Executive Director Serena Clayton, PhD. “We are grateful
to CompuMed for its support of our mission to promote the health and academic
success of children and youth by putting health care where the kids are – in
school.”

While the recession has caused many school districts to rethink healthcare
spending, CompuMed has made its equipment, software and over-reads extremely
affordable for school clinics. The equipment to perform ECGs is provided free of
charge, even though it typically costs about $3,500. Each CompuMed over-read by
a skilled pediatric cardiologist is reasonably priced at $15, though typically
priced in the marketplace from $20 to $150 or more.

According to recent estimates, five to 10 percent of elementary and secondary
students in the U.S. today may have undiagnosed heart conditions ranging from
mild hypertrophy to life-threatening arrhythmias. Approximately 95 percent of
the most serious of these conditions can be detected by an ECG over-read by a
pediatric cardiologist. Using CompuMed technology, students can receive an ECG
as part of routine pediatric primary care, athletic pre-participation screenings
or psychotropic medication monitoring programs performed by school health
centers. The test over-read is then performed by a pediatric cardiologist for a
fraction of the cost of traditional methods.

“We are thrilled to partner with CSHC to educate school health centers about
CompuMed`s ECG telemedicine technology and services,” said CompuMed CEO Maurizio
Vecchione. “CSHC has been at the forefront of the school-based healthcare
movement and is among the most esteemed healthcare advocacy groups in
California. There isn`t a better group for us to work with at this stage in our
deployment.”

According to CompuMed’s lead cardiologist David M. Frisch, M.D., F.A.C.C:
“Several other nations already require that ECGs be performed on students prior
to participation in competitive athletics, as do most colleges in the U.S. and
the NCAA. Recent guidelines from the American Heart Association (AHA) stop short
of extending such a recommendation to cover all students in the U.S. The AHA
cites logistical and cost issues involved in having traditional ECGs performed
on children and adolescents and then over-read by pediatric cardiologists.
CompuMed`s ECG telemedicine technology and the emergence of school-based health
centers change this cost equation and ease the logistical burden dramatically.”

A student athlete`s heart attack is a shocking event, and can have serious
emotional impact upon a school and local community. CompuMed is committed to
reducing the likelihood of these tragic events. “In communities where ECGs with
pediatric cardiology over-reads are performed on all students prior to athletic
participation, the incidence of sudden cardiac deaths among student athletes has
been reduced by more than 90 percent,” said Dr. Frisch.

A recent national study has found a significant increase in health care access
in general by students who used school health centers; 71 percent of students
reported having a health care visit in the past year compared to 59 percent of
students who did not have access to a center.

Added Vecchione: “We are in the early stages of what we believe is a major
paradigm shift in the delivery of high quality, affordable health care to our
nation`s youth and other previously underserved populations. By enabling
widespread access to state-of-the-art preventive health care, products and
services like our ECG telemedicine technology can reduce overall healthcare
costs while improving the quality of care in the U.S. and worldwide.”

About CardioGram and CardioGramKids

CompuMed`s CardioGram and CardioGramKids are a portable devices supported by
proprietary work-flow software, with unique features designed to appeal to the
cost-saving trends in eHealth, and makes performing a 12-lead ECG easier and
more cost-efficient.

After patient preparation, the ECG is acquired with the push of a button. The
ECG data is digitally transmitted via any phone or Internet connection to the
company`s computer laboratory for instant analysis. ECG data is interpreted by
sophisticated computer algorithm, and interpretations are available in near
real-time at the CardioGram device. The data and interpretation can then be
transferred to an electronic medical record (EMR) via CompuMed`s proprietary EMR
software solution.

CompuMed`s EMR software also allows the company`s laboratory to process ECGs for
any customer from any location, regardless of the brand of ECG machine used.
However, the most unique and life-saving feature of the CardioGram is the
device`s over-read capabilities or “The Doctor Inside,” which immediately
engages one of CompuMed`s on-call cardiologists to over-read the computerized
interpretation. Cardiologist-generated interpretations can be made available to
attending physicians at the point-of-care, providing expert interpretations in
those situations where the data is ambiguous or difficult to interpret. The
Doctor Inside is a key element of CompuMed`s unique approach to telemedicine and
telecardiology.

About California School Health Centers Association

The California School Health Centers Association (CSHC) is the nonprofit
membership and advocacy organization leading the movement to put health care
where kids are — in schools. CSHC pursues this mission by advocating for public
policies that support school health centers, building support among
policymakers, community leaders, parents and students, and providing technical
support to new and existing school health centers. There are 153 school health
centers in California serving more than a quarter million students. CSHC’s
members include California’s 153 school health centers and other individuals and
organizations that support school-based health care. For more information about
CSHC and its programs, visit www.schoolhealthcenters.org.

About CompuMed

CompuMed, Inc. (NASDAQ OTC: CMPD) develops and markets products and services
that combine advanced imaging with medical informatics. Its focus is on analysis
and remote monitoring for patients with cardiovascular and musculoskeletal
diseases. The company has specialized expertise and intellectual property in
telemonitoring imaging and analysis designed to improve healthcare provider
workflow and patient care while reducing costs. CompuMed is headquartered in Los
Angeles and distributes its products worldwide both directly and through OEM
partners. Visit CompuMed at www.compumed.net and follow at Twitter: @compumed.
To receive a corporate profile on CompuMed or to learn more about the company’s
progress, please contact Liolios Group at 949-574-3860 or email
info@liolios.com.

Forward Looking Statements

Statements contained in this press release that are not historical facts, such
as statements about prospective earnings, savings, revenue, operations, revenue
and earnings growth, results of contracts and other financial results, are
forward-looking statements pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. All such forward-looking statements
including statements concerning the Company’s plans, objectives, expectations
and intentions are based largely on management’s expectations and are subject to
and qualified by risks and uncertainties that could cause actual results to
differ materially from those expressed or implied by such statements. These
statements are subject to uncertainties and risks including, without limitation,
competitive factors, outsourcing trends in the pharmaceutical industry, product
and service demand and acceptance, changes in technology, ability to raise
capital, the availability of appropriate acquisition candidates and/or business
partnerships, economic conditions, the impact of competition and pricing,
capacity and supply constraints or difficulties, government regulation and other
risks identified in the Company’s filings with the Securities and Exchange
Commission including its Annual Report on Form 10-KSB and Quarterly Reports on
Form 10-QSB. All such forward-looking statements are expressly qualified by
these cautionary statements. The Company expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any forward-looking
statements to reflect events, conditions or circumstances on which any such
statement is based after the date hereof, except as required by law.

Press Contact
Tellem Worldwide
Susan Tellem, 310-313-3444
stellem@tellem.com
or
Investor Relations Contacts
Liolios Group, Inc.
Ron Both or Cody Slach, 949-574-3860
info@liolios.com

Copyright Business Wire 2010